Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEADER 7 cataract surgery eye drop study
2018-000286-36Phase 3Completed
- Sponsor
- NTC Pharma
- Start
- Jun 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in Postoperative ocular inflammation, postoperative endophthalmitis and cataract comparing Levofloxacin + dexamethasone then dexamethasone with Tobramycin + dexamethasone (2 arms). Primary endpoint: Absence of anterior chamber inflammation. Started Jun 2018; status: completed.
02
Drugs
levofloxacindexamethasonetobramycin
03
Conditions
Postoperative ocular inflammationpostoperative endophthalmitiscataract
Beyond the preview
Go deeper on 2018-000286-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000286-36.